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Purpose: To identify the differentially expressed genes (DEGs) in the human keratocytes in keratoconus.
Methods: Total RNA extracted from cultured corneal stromal fibroblasts from normal and keratoconic corneas were used
for  the  synthesis  of  cDNA.  DEGs  were  screened  by  an  annealing  control  primerTM-based  PCR  method  using
GeneFishing™ DEG kits. The differentially expressed bands were sequenced and analyzed. The genes identified were
further evaluated by reverse transcriptase PCR and quantitative real-time PCR.
Results:  Overexpression  of  bone  morphogenetic  protein  4  (BMP4),  cofilin  1  (CFL1),  and  JAW1-related  protein
(MRVI1) and underexpression of actin, alpha 2 (ACTA2), gene rich cluster, and C 10 gene (GRCC10), tissue inhibitor of
metalloproteinase 3 (TIMP3), tissue inhibitor of metalloproteinase 1 (TIMP1), and somatostatin receptor 1 (SSTR1) were
verified, and these results were confirmed by reverse transcriptase PCR and quantitative real-time PCR.
Conclusions: Eight genes were identified to be differentially expressed in keratoconus and related with apoptosis, the
cytoskeleton, wound healing, and nerve fibers. The genes identified may be involved in the mechanism underlying stromal
thinning; thus, they could be important and deserve further investigation.
Keratoconus is characterized by thinning of the corneal
stroma, but its pathological mechanism has not been fully
elucidated. Clinical studies have suggested that the disease has
a high incidence among long-term users of contact lenses,
often attacks those who have a history of rubbing their eyes,
and is related to atopy of the eye [1-4]. Therefore, it is believed
that the long-term damage to and stimulation of the corneal
epithelium play a key role in the pathogenesis of keratoconus.
Furthermore,  it  has  been  proven  that  when  the  corneal
epithelium  is  damaged,  surrounding  stromal  keratocytes
disappear due to apoptosis, and that an imbalance between cell
death  and  proliferation  is  involved  in  the  pathological
mechanism  of  keratoconus.  The  apoptosis  of  keratocytes
plays an important role in the corneal thinning in keratoconus
[5].  Hence,  it  is  valuable  to  investigate  the  genes  of  the
keratocytes that are involved in the thinning of the cornea
because  the  it  is  important  to  grasp  the  fundamental
pathogenesis in order to understand and treat the disease of
keratoconus.  Even  though  there  have  been  studies  on  the
morphologic or ultrastructural differences between normal
and  keratoconic  cornea,  there  are  few  reports  on  their
differentially expressed genes (DEGs) [6-9]. Kim et al. [6-8]
compared the differential gene expression in the keratoconic
and normal corneal epithelium using microarray focusing on
the  epithelium;  their  study  had  the  advantage  of  early
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detection using the simple gene expression analysis of the
scraped-off epithelium. Ha et al. [9] used keratoconic and
normal cultured keratocyte and complementary DNA (cDNA)
microarrays to find apoptosis-related genes, and concentrated
on the importance of programmed cell death as having a
crucial role in the corneal thinning in keratoconus. In this
study,  we  investigated  the  DEGs  between  normal  and
keratoconic cultured corneal stromal fibroblasts; the results
could be used as preliminary data for further study of the
molecular mechanism underlying keratoconus.
METHODS
Culture of human keratocytes: This study was conducted in
accordance with the tenets of the Declaration of Helsinki.
Normal corneas were obtained using human donor corneas
that had been discarded before transplantation due to mild
endothelial  polymorphous  dystrophy,  and  keratoconic
corneas  came  from  patients  with  keratoconus  found  at
keratoplasty  with  informed  consent.  This  study  used  five
samples each of normal and keratoconic corneas. Stromal
explants  were  prepared  by  removing  the  epithelium  and
endothelium, followed by culturing in Dulbecco's Modified
Eagle Medium (DMEM; Gibco, BRL, NY), that contains 10%
fetal  bovine  serum  (FBS;  Gibco),  100  units/ml  penicillin
(Gibco),  and  100  mg/ml  streptomycin  (Gibco).  Culture
medium was replaced every two to three days. When the cells
reached  confluence,  the  culture  medium  was  completely
removed  and  the  cells  were  washed  with  Dulbecco's
Phosphate-Buffered  Saline  (D-PBS;  Gibco)  and  detached
enzymatically with 0.25% trypsin–0.02% EDTA (Gibco). For
genetic analysis, cultured corneal stromal fibroblasts of the
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2480third to fourth passage were collected and kept at -70 °C until
used for experiments.
Messenger  RNA  isolation:  Using  the  RNeasy®  mini  kit
(QIAGEN Inc., Valencia, CA), all RNA was extracted from
the  cultured  corneal  stromal  fibroblasts  of  normal  and
keratoconic corneas that were cultured for genetic analysis.
First, the buffer was added to the cell pellets and they were
homogenized for 30 s using a rotor-stator homogenizer. After
adding the ethanol and mixing well by pipetting, the top layer
solution  that  contained  RNA  was  applied  to  an  RNeasy®
minicolumn (QIAGEN Inc.) placed in a collection tube. After
repeating the processes of centrifugation, washing, and adding
the buffer, the remaining solution was centrifuged and RNase-
free  water  was  used  to  elute  the  RNA.  The  separated
messenger  RNA  (mRNA)  was  measured  and  checked  by
electrophoresis.
cDNA Synthesis: The mRNA extracted from cultured corneal
stromal fibroblasts was employed for the synthesis of first-
strand cDNA by reverse transcriptase, as described by Hwang
et al. [10]. Reverse transcription was performed for 1.5 h at
42 °C in a final reaction volume of 20 μl containing 3 μg of
the purified total RNA, 4 μl of 5× reaction buffer (Promega,
Madison, WI), 5 μl of deoxyribonucleotide triphosphate (each
2  mmol),  2  μl  of  10  μmol  cDNA  synthesis  primer
deoxythiamine annealing control primer 1 (dT-ACP1; Table
1), 0.5 μl of RNasin® RNase Inhibitor (40 U/μl; Promega), and
1 μl of Moloney murine leukemia virus reverse transcriptase
(200 U/μl; Promega). First-strand cDNA was diluted by the
addition  of  80  μl  of  ultra-purified  water  for  the
GeneFishing™ PCR, and stored at -20 °C until use.
Annealing control primer™-based GeneFishing™ PCR: DEGs
were screened by the annealing control primer (ACP)™-based
PCR method using the GeneFishing™ DEG kits (Seegene,
Seoul, South Korea) [11]. The GeneFishing™ PCR technique
involved an ACP™ system that had a unique tripartite structure
in that its distinct 3’-end target core sequence and 5’-end non-
target  universal  sequence  portions  were  separated  by  a
regulator, it used primers that annealed specifically to the
template,  and  it  allowed  only  genuine  products  to  be
amplified; this process that eliminated false positive results.
Second-strand  cDNA  synthesis  and  subsequent  PCR
amplification  were  conducted  in  a  single  tube.  Briefly,
second-strand cDNA synthesis was conducted at 50 °C (low
stringency) during one cycle of first-stage PCR in a final
reaction volume of 49.5 μl containing 3–5 μl (about 50 ng) of
diluted first-strand cDNA, 5 μl of 10× PCR buffer plus Mg
(Roche Applied Science, Mannheim, Germany), 5 μl of dNTP
(each 2 mM), 1 μl of 10 μM dT-ACP2, and 1 μl of 10 μM
arbitrary  primer  preheated  to  94  °C  (Table  1).  The  tube
containing the reaction mixture was held at 94 ºC, while 0.5
μl of Taq DNA Polymerase (5 U/μl; Roche Applied Science)
was added to the reaction mixture. The PCR protocol for
second-strand synthesis was one cycle at 94 ºC for 1 min,
followed by 50 ºC for 3 min, and 72 ºC for 1 min. After the
completion of second-strand DNA synthesis, 40 cycles were
performed. Each cycle involved denaturation at 94 ºC for 40
s, annealing at 65 ºC for 40 s, extension at 72 ºC for 40 s, and
a  final  extension  at  72  ºC  to  complete  the  reaction.  The
amplified PCR products were separated in 2% agarose gel
stained with ethidium bromide.
Cloning and sequencing: The differentially expressed bands
were extracted from the gel using the GENCLEAN® II Kit (Q-
BIO gene, Carlsbad, CA), and directly cloned into a TOPO
TA®  cloning  vector  (Invitrogen,  Karlsruhe,  Germany)
according  to  the  manufacturer’s  instructions.  The  cloned
plasmids were sequenced with an ABI PRISM® 3100 Genetic
Analyzer (Applied Biosystems, Foster City, CA). Complete
sequences were analyzed by searching for similarities using
the  Basic  Local  Alignment  Search  Tool  (BLAST)  search
program  at  the  National  Center  for  Biotechnology
Information GenBank [12].
Reverse  transcriptase-polymerase  chain  reaction  and
quantitative  real-time  PCR  confirmation:  The  differential
expression of DEGs was confirmed by reverse transcriptase–
polymerase  chain  reaction  (RT-PCR)  using  each  gene-
specific  primer  pair.  The  primer  sets  and  annealing
temperatures for eight genes are shown in Table 2. The cDNA
was amplified using primers derived from the sequence of the
DEGs  and  glyceraldehydes  3-phosphate  dehydrogenase
(GAPDH)  as  a  control  reference.  The  PCR  reaction  was
TABLE 1. PRIMER SEQUENCE USED IN CDNA SYNTHESIS AND ACP™-BASED PCR.
Use Primer name Sequence
cDNA synthesis primer dT-ACP1 5’-CTGTGAATGCTGCGACTACGATIIIII(T) 18-3’
Reverse primer dT-ACP2 5’-CTGTGAATGCTGCGACTACGATIIIII(T) 15-3’
Arbitrary primer ACP12 5’-GTCTACCAGGCATTCGCTTCATIIIIIGCCAGGAAGA-3’
(forward primer) ACP17 5’-GTCTACCAGGCATTCGCTTCATIIIIICCATGAAGAT-3’
  ACP21 5’-GTCTACCAGGCATTCGCTTCATIIIIIGGCCCTGGAT-3’
  ACP22 5’-GTCTACCAGGCATTCGCTTCATIIIIIAGTTCGTGGG-3’
  ACP25 5’-GTCTACCAGGCATTCGCTTCATIIIIICCTACGCCAC-3’
  ACP27 5’-GTCTACCAGGCATTCGCTTCATIIIIIATTATTTATA-3’
  ACP28 5’-GTCTACCAGGCATTCGCTTCATIIIIICCTTGAGCGC-3’
  ACP31 5’-GTCTACCAGGCATTCGCTTCATIIIIIAGGAAAAAAG-3’
ACP, annealing control primer; The polydeoxyinosine [poly(dI)] linkers are underlined. In the table, "I" represents deoxyinosine.
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μl (about 50 ng) of diluted first-strand cDNA, 1 μl of primer
5’ (10 μM), 1 μl of primer 3’ (10 μM), and 10 μl of 2× Master
Mix®  (Seegene).  The  PCR  amplification  protocol  was  an
initial 3 min denaturation at 94 ºC, followed by 20–25 cycles
of 94 ºC for 40 s, 60 ºC for 40 s, 72 ºC for 40 s, and a 5 min
final extension at 72 ºC. The amplified PCR products were
separated in 2% agarose gel stained with ethidium bromide.
Quantitative real-time PCR was performed in triplicate
in 384-well plates; each 20 μl reaction consisted of 10 μl of
SYBR Green Master Mix (Applied Biosystems), 0.5 μl of
template (10 ng/μl), and 0.8 μl of 10 pM forward and reverse
primers of DEGs and GAPDH as control reference (Table 2).
The PCR amplification protocol was 50 °C for 2 min and 95
°C for 10 min followed by 40 cycles of 95 °C for 30 s, 60 °C
for 30 s, and 72 °C for 30 s. Each of the 384-well quantitative
real-time PCR plates included serial dilutions (1, 1/2, 1/4, 1/8,
and 1/16) of cDNA, which were used to generate relative
standard curves for DEGs and GAPDH. The real-time PCR
analysis was performed on an Applied Biosystems Prism 7900
Sequence Detection System (Applied Biosystems). Relative
quantitation with the data obtaining was performed using the
relative  standard  curve  method  according  to  the  user’s
manual. In the relative standard curve method, one of the
experimental samples (keratoconus or normal cornea) can be
used as the calibrator. Following this method, in the present
study, each relative value was divided by the value of the
calibrator and the relative expression was presented as the n-
fold difference compared to the calibrator.
RESULTS
The  analysis  was  performed  with  5  pairs  of  normal  and
keratoconic samples. To identify DEGs, mRNA from normal
and  keratoconic  corneas  was  extracted  and  subjected  to
ACP™ analysis using a combination of 120 arbitrary primers
and two anchored oligo (dT) primers (dT-ACP 1 and dT-ACP
2). On the basis of the differential expression levels of the
mRNA  fragments  observed  on  the  agarose  gels,  8  bands
showed the same differential patterns in all 5 pairs of normal
and  keratoconic  samples.  Homology  searching  using  the
Basic  Local  Alignment  Search  Tool  revealed  their  likely
identities (Figure 1; Table 2). Three (bone morphogenetic
protein 4 [BMP4], cofilin 1 [CFL1], and JAW1-related protein
[MRVI1]) were found to be markedly upregulated genes in
keratoconus,  while  the  remaining  five  (actin,  alpha  2
[ACTA2], gene rich cluster, and C 10 gene [GRCC10], tissue
inhibitor of metalloproteinase 3 [TIMP3], tissue inhibitor of
metalloproteinase 1 [TIMP1], and somatostatin receptor 1
[SSTR1]) were downregulated.
The expression patterns of the DEGs were confirmed by
RT-PCR. The RT-PCR assays revealed that in agreement with
the ACP™ differential display, 8 bands had similar expression
patterns (Figure 2). The results of the ACP™ analysis were also
validated with quantitative real-time PCR. Data obtained after
normalization  to  GAPDH  showed  that,  in  keratoconus,
BMP4 increased 1.6 fold (Figure 3A), CFL1 increased 3.3 fold
(Figure 3B), MVI1 increased 11 fold (Figure 3C), ACTA2
decreased by nearly 4.5 fold (Figure 3D), GRCC10 decreased
by 2.7 fold (Figure 3E), TIMP3 decreased by nearly 14 fold
(Figure 3F), TIMP1 decreased by 8.5 fold (Figure 3G), and
SSTR1 decreased by 1.8 fold (Figure 3H) relative to a normal
cornea. The quantitative real-time PCR assay also revealed
similar expression patterns in agreement with the results of
ACP™ differential display.
DISCUSSION
Recently,  to  identify  differences  in  gene  expression,
microarray analysis with DNA chips has been often used
TABLE 2. CHARACTERISTICS AND SEQUENCE-SPECIFIC PRIMERS USED FOR RT-PCR AND QUANTITATIVE REAL-TIME PCR OF 8 DIFFERENTIALLY EXPRESSED GENES.
Gene
GenBank






Bone morphogenetic protein 4 (BMP4) NM_130850 F: GGGCACCTCATCACACGAC
    R: TGGGCACACAACAGGCTTT 60 550
Cofilin 1 (CFL1) BC011005 F: TTCTGCGGCTCTCGGTG
    R: GCTTCTCTGCCAGGGTG 60 499
JAW1-related protein (MRVI1) XM_001166452 F: TGTGGATCTGAAGAGTCC CCCA
    R: ACAGTTCAATGCTAGCACACCTG 60 282
Actin, alpha 2 (ACTA2) BC017554 F: CCTCCCTTGAGAAGAGTTACG
    R: GAGCAGGAAAGTGTTTTAGAA 60 443
Gene rich cluster and C 10 gene (GRCC10) BC009925 F; CGTGGCTCTTTATTCGTGA
    R: GGGCTTCGTAGGACTTGAC 60 333
Tissue inhibitor of metalloproteinase 3 (TIMP3) NM_000362 F: AAGCGATGTCAGAGGGCG
    R: AACTGGATGGGCAGCAGG 60 465
Tissue inhibitor of metalloproteinase 1 (TIMP1) NM_003254 F: GTTCCAAGCCTTAGGGGATGC
    R: TGACGTAGTCAGGTCCACCAC T 60 407
Somatostatin receptor 1 (SSTR1) NM_001049 F: CTGGCTTGTACATAGTAGGCAC
    R:CAATGGTAACAAGTTAAGAGCACT 60 426
In the table, "F" indicates forward strand and "R" indicates reverse strand.
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scale  expression  surveys  to  identify  the  genes  whose
expression is altered in a disease. However, the change in
expression  of  each  gene  spot  could  be  variable  between
sample  pairs  and  within  duplicates.  This  may  be  due  to
different  incorporation  efficiencies  of  Cy-3  and  Cy-5
fluorescence dyes, which may consequently generate variable
signal intensity. Therefore, it was necessary to repeat array
analysis with different sample pairs in order to find frequently
altered genes with a more or less stable pattern of change.
In this study, we employed the new differential display
GeneFishing™ PCR technique to compare the gene expression
in normal and keratoconic corneas [10,11]. Difficulty often
arises  in  identifying  a  gene  responsible  for  a  specialized
Figure 1. Annealing control primer™–
base  polymerase  chain  reaction.
Annealing  control  primer™–base
polymerase  chain  reaction  product  of
eight  verified  differentially  expressed
genes  shows  increased  or  decreased
levels  of  expression  in  keratoconus
(arrows). Higher levels of expression in
keratoconus (column 2) compared with
normal cornea (column 1) were found in
bone  morphogenetic  protein  4  (A),
cofilin 1 (B), and JAW1-related protein
(C), whereas lower levels of expression
were found in actin, alpha 2 (D), gene
rich cluster, and C 10 gene (E), tissue
inhibitor  of  metalloproteinase  3  (F),
tissue inhibitor of metalloproteinase 1
(G), and somatostatin receptor 1 (H).
Figure  2.  Depicted  are  reverse
transcriptase-polymerase chain reaction
products of the eight verified genes and
glyceraldehydes  3-phosphate
dehydrogenase  (GAPDH)  as  a
housekeeping  gene.  Bone
morphogenetic  protein  4  (BMP4;  A),
JAW1-related protein (MRVI1; B), and
cofilin 1 (CFL1; C) were significantly
increased, while actin, alpha 2 (ACTA2;
D), gene rich cluster, and C 10 gene
(GRCC10;  E),  tissue  inhibitor  of
metalloproteinase 3 (TIMP 3; F), tissue
inhibitor  of  metalloproteinase  1
(TIMP1; G), and somatostatin receptor
1  (SSTR1;  H)  were  significantly
decreased in keratoconus (colummn 2)
compared with normal cornea (column
1).
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2483function during a certain biological stage because the gene is
expressed at low levels, whereas the bulk of mRNA transcripts
within  a  cell  are  highly  abundant  [14].  To  screen  DEG
transcripts in low concentrations while minimizing the false
positive  results,  it  was  reasonable  to  use  a  PCR-based
technique.  Moreover,  it  was  possible  to  detect
GeneFishing™  technology  reaction  products  easily  on
ethidium bromide–stained agarose gel. This is supposed to
greatly assist studies searching for genes that are expressed
differentially in cells under various physiological stages or
experimental conditions. However, one of the concerns in this
study was the effect of the culturing process; the other was the
age and sex matching of sample pairs, which was not possible
due to the difficulty in obtaining corneas. With this technique,
we identified eight DEGs that are specifically expressed or
lacking in keratoconus as compared to normal corneas.
We found that BMP4 was expressed significantly more
highly in keratoconus than in normal corneas. BMP4 is known
to mediate apoptosis or alternative developmental fates of
neural  crest  and  other  types  of  cells  during  development
[15-17]. BMP4 and its receptor are found in all cell types
(epithelial  cells,  keratocytes,  and  endothelial  cells)  of  the
human cornea [18,19]. Because keratocytes are derived from
neural crest, BMP4 stimulates apoptosis in corneal fibroblasts
and  has  a  role  in  mediating  keratocyte  proliferation  and
apoptosis in the cornea [15-20]. From the higher expression
of BMP4 in keratoconus in this study, it was suggested that
BMP4 might play an important role in mediating the apoptosis
of keratocytes in keratoconus.
CFL1 is well characterized as an actin depolymerization
factor and crucial for many cellular processes, such as cell
motility, cell division, and membrane organization. Binding
of CFL1 to actin filaments alters the twist of the filament,
Figure  3.  Quantitative  real-time
polymerase chain reaction. Quantitative
real-time polymerase chain reaction of
the  eight  verified  genes  using
glyceraldehydes  3-phosphate
dehydrogenase  (GAPDH)  as
endogenous control showed that bone
morphogenetic  protein  4  (BMP4;  A),
cofilin  1  (CFL1;  B),  JAW1-related
protein (MRVI1; C) were increased by
1.6,  3.3,  and  11  fold,  respectively,
whereas actin, alpha 2 (ACTA2; D), gene
rich cluster, and C 10 gene (GRCC10;
E), tissue inhibitor of metalloproteinase
3  (TIMP3;  F),  tissue  inhibitor  of
metalloproteinase  1  (TIMP1;  G),  and
somatostatin  receptor  1  (SSTR1;  H)
were decreased by 4.5, 2.7, 14, 8.5, and
1.8  fold,  respectively  in  keratoconus
relatively to norma l cornea.
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2484thereby promoting filament severing and depolymerization.
CFL1  is  involved  in  the  organization  of  the  cytoskeleton
[21,22]. It also has an important function during the initiation
phase of apoptosis, which it induces by being translocated to
mitochondria  during  the  initial  stage  of  apoptosis  [23].
CFL1 was also a gene whose expression was increased in
keratoconus.
MRVI1, although no function of this gene is well known,
is involved in the control of growth and/or differentiation of
hematopoietic cells, and supposed to be a tumor suppressor
gene.  MRVI1  functions  as  cofactor  in  several  signaling-
transduction  systems  that  affect  cellular  growth,
differentiation, motility, and adhesion [24]. Although it has
not been studied in the tissue of cornea, the upregulation of
MRVI1 in keratoconus in this study suggested that MRVI1
might  retard  the  cell  cycle  of  keratocytes  and  affect  the
cytoskeleton as well as wound healing. Further studies of
MRVI1  involving  the  cornea  should  help  to  define  the
mechanism of keratoconus related with the MRVI1 gene.
Meanwhile,  ACTA2,  which  has  been  known  to  be
involved in the cytoskeleton [25], showed low expression in
keratoconus. ACTA2 is a functional marker for a fibroblast
subtype that rapidly remodels the extracellular matrix [26].
Keratocytes can become myofibroblasts during corneal injury
and wound healing, and the transformation of keratocytes into
myofibroblasts is a key point in the healing process [27].
Myofibroblast  cells  are  characterized  by  alpha–smooth
muscle  actin  expression  and  have  additional  differences
relative to keratocytes that include increased production of
growth factors, collagen, glycosaminoglycans, collagenases,
gelatinases,  and  metalloproteinases  associated  with
remodeling  of  the  collagen  and  the  stroma.  ACTA2  is
expressed at the mRNA level within 24 h of injury to the
corneal stroma, is expressed at the protein level at day 3, and
declines at the mRNA level by day 5. Therefore, ACTA2 is
important for the wound healing process and the cytoskeleton
[28,29]. Although alpha smooth muscle actin is normally not
expressed  in  significant  levels  in  keratocytes  and  the
expression of the ACTA2 gene in the normal cornea could be
affected  by  culture  process,  it  is  possible  for  normal
keratocytes to express this gene in case of the potential corneal
injury, and further study of ACTA2 should be undertaken.
GRCC10  is  located  at  the  CD4  locus  on  human
chromosome 12p13 and possesses diverse expression patterns
and functions, ranging from signal transduction and glycolysis
to regulation of cell proliferation and ubiquitin-dependent
proteolysis [30,31]. The underexpression of genes such as
ACTA2 and GRCC10 in keratoconus was believed to delay the
growth of keratocytes that were necessary for the synthesis
and  maintenance  of  collagen  fibrils  and  the  extracellular
matrix.
It is known that there are four types of tissue inhibitor of
metalloproteinase (TIMP), and especially TIMP3 has been
reported to exist only in interstitial substances. The role of this
gene is to control the balance between the destruction and
reformation of the corneal tissue by inhibiting the action of
matrix metalloproteinase to protect tissues from irreversible
destruction  and  suppress  angiogenesis  [32].  Because  the
expression of TIMP3 in keratoconus was decreased relative
to the normal cornea, it was suggested that the decreased
expression of this gene caused the imbalance between the
destruction  and  reformation  of  interstitial  substances.  In
agreement  with  this,  it  has  already  been  reported  that
increased  matrix  metalloproteinase  and  decreased  TIMP
levels are related to the formation of keratoconus [33-35].
The  level  of  TIMP1  also  decreased  significantly  in
keratoconus  compared  with  the  normal  cornea.  Although
keratoconus  does  not  involve  extensive  scarring  or
inflammatory  infiltrates,  considerable  degradation  of  the
extracellular  matrix  occurs  [36,37].  A  decreased  level  of
TIMP1 increases gelatinase activities and apoptosis, which
are found in keratoconus [34,38-41]. Decreased TIMP1 might
play a role in the matrix degradation that was the hallmark of
keratoconus.
We found that SSTR1 expression was downregulated in
keratoconus.  The  cell-specific  distribution  of  SSTR1  in
normal human eye tissue has been reported, and SSTR1 is
found  on  the  cell  membrane  and  cytoplasm  of  stromal
keratocytes [42]. Somatostatin is a ubiquitously distributed
cyclic neuropeptide that has diverse biological functions, the
most  important  of  which  are  its  neurotransmitter,
antisecretory, and antiproliferative functions [43,44]. It has
been  reported  that  corneal  nerves  may  play  a  role  in  the
development and progression of keratoconus, with support for
this hypothesis coming from the close proximity of stromal
nerve changes to breaks in Bowman’s membrane and the
progression  of  keratoconus  observed  in  a  patient  with
unilateral fifth cranial nerve palsy [45-47]. The significant
alteration  in  corneal  nerves  in  keratoconus  has  been  also
documented with a subbasal nerve fiber density 52.7% lower
than that in control eyes, and a correlation between nerve
density and severity of disease [48], although whether these
alterations  play  a  causative  role  or  are  secondary
manifestations of the underlying disease remains unknown.
These studies indicate that the decreased expression of SSTR1
as  a  receptor  for  neuropeptides  might  be  involved  in  the
pathophysiology of keratoconus.
It has been a common experience of many investigators
to find genes that are identified as differentially expressed but
that cannot be verified by other independent means. However,
we assessed the expression of eight genes in more detail by
employing RT-PCR and real-time PCR, which confirmed the
overexpression  of  BMP4,  CFL1,  and  MRVI1,  and  the
underexpression of ACTA2, GRCC10, TIMP3, TIMP1, and
SSTR1 in keratoconus.
We found differential expression of the eight genes in
relation to apoptosis, cytoskeleton structure, wound healing,
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2485and  nerve  fiber  density  in  keratoconus  using  the
GeneFishing™ PCR technique. The ACP™-based strategy was
easy,  showed  a  lack  of  false  positives,  and  yielded
reproducible results. Although the detailed function of these
genes and their products remain to be determined, they could
be  important  and  deserve  further  investigation,  and  their
identification  in  this  study  provides  preliminary  data  for
further  study  of  the  molecular  mechanism  underlying
keratoconus.
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